The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
116081253 11608125 3 F 20121207 20160624 20151007 20160706 EXP US-APOTEX-2015AP013209 APOTEX 69.00 YR F Y 0.00000 20160706 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
116081253 11608125 1 PS TOBRAMYCIN OPHTHALMIC SOLUTION USP 0.3% TOBRAMYCIN 1 Other 10.8 G, UNK 65087 10.8 G EYE DROPS, SOLUTION
116081253 11608125 2 SS TOBRAMYCIN OPHTHALMIC SOLUTION USP 0.3% TOBRAMYCIN 1 Other 3.6 G, UNK 65087 3.6 G EYE DROPS, SOLUTION
116081253 11608125 3 SS LISINOPRIL. LISINOPRIL 1 Oral 20 MG, UNK Y 0 20 MG TABLET
116081253 11608125 4 SS PIPERACILLIN AND TAZOBACTAM PIPERACILLIN SODIUMTAZOBACTAM SODIUM 1 Intravenous (not otherwise specified) 3.375 MG, EVERY 6 HOURS Y 0 3.375 MG INJECTION Q6H
116081253 11608125 5 SS VANCOMYCIN VANCOMYCIN 1 Intravenous (not otherwise specified) Y 0
116081253 11608125 6 SS VANCOMYCIN VANCOMYCIN 1 Other 12 G+4G Y 0
116081253 11608125 7 SS VANCOMYCIN VANCOMYCIN 1 Intravenous (not otherwise specified) 1 G, BID Y 0 1 G BID
116081253 11608125 8 SS VANCOMYCIN VANCOMYCIN 1 Intravenous (not otherwise specified) 750 MG, BID Y 0 750 MG BID
116081253 11608125 9 C DULOXETINE. DULOXETINE 1 Unknown U U 0
116081253 11608125 10 C SOLIFENACIN SOLIFENACIN 1 Unknown U U 0
116081253 11608125 11 C AMLODIPINE AMLODIPINE BESYLATE 1 Unknown U U 0
116081253 11608125 12 C HYDROCODONE/PARACETAMOL ACETAMINOPHENHYDROCODONE BITARTRATE 1 Unknown U U 0
116081253 11608125 13 C MORPHINE MORPHINE 1 Unknown U U 0
116081253 11608125 14 C PAROXETINE. PAROXETINE 1 Unknown U U 0
116081253 11608125 15 C RIFAMPIN. RIFAMPIN 1 Oral U U 0
116081253 11608125 16 C CEPHALEXIN /00145501/ CEPHALEXIN 1 Oral U U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
116081253 11608125 1 Infection prophylaxis
116081253 11608125 3 Product used for unknown indication
116081253 11608125 4 Product used for unknown indication
116081253 11608125 5 Product used for unknown indication
116081253 11608125 9 Product used for unknown indication
116081253 11608125 10 Product used for unknown indication
116081253 11608125 11 Product used for unknown indication
116081253 11608125 12 Product used for unknown indication
116081253 11608125 13 Product used for unknown indication
116081253 11608125 14 Product used for unknown indication
116081253 11608125 15 Product used for unknown indication
116081253 11608125 16 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
116081253 11608125 OT
116081253 11608125 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
116081253 11608125 Acute kidney injury
116081253 11608125 Arthritis bacterial
116081253 11608125 Drug level increased
116081253 11608125 Haemoglobin decreased
116081253 11608125 Hypotension
116081253 11608125 Leg amputation
116081253 11608125 Renal tubular necrosis

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found